vs

Side-by-side financial comparison of POWER SOLUTIONS INTERNATIONAL, INC. (PSIX) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

POWER SOLUTIONS INTERNATIONAL, INC. is the larger business by last-quarter revenue ($191.2M vs $158.6M, roughly 1.2× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 8.4%, a 62.8% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 32.5%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-7.6M).

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

PSIX vs STOK — Head-to-Head

Bigger by revenue
PSIX
PSIX
1.2× larger
PSIX
$191.2M
$158.6M
STOK
Growing faster (revenue YoY)
STOK
STOK
+3628.6% gap
STOK
3661.1%
32.5%
PSIX
Higher net margin
STOK
STOK
62.8% more per $
STOK
71.2%
8.4%
PSIX
More free cash flow
STOK
STOK
$139.3M more FCF
STOK
$131.7M
$-7.6M
PSIX

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
PSIX
PSIX
STOK
STOK
Revenue
$191.2M
$158.6M
Net Profit
$16.1M
$112.9M
Gross Margin
21.9%
Operating Margin
12.7%
70.2%
Net Margin
8.4%
71.2%
Revenue YoY
32.5%
3661.1%
Net Profit YoY
-31.0%
528.0%
EPS (diluted)
$0.69
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PSIX
PSIX
STOK
STOK
Q4 25
$191.2M
Q3 25
$203.8M
Q2 25
$191.9M
Q1 25
$135.4M
$158.6M
Q4 24
$144.3M
$22.6M
Q3 24
$125.8M
Q2 24
$110.6M
Q1 24
$95.2M
Net Profit
PSIX
PSIX
STOK
STOK
Q4 25
$16.1M
Q3 25
$27.6M
Q2 25
$51.2M
Q1 25
$19.1M
$112.9M
Q4 24
$23.3M
$-10.5M
Q3 24
$17.3M
Q2 24
$21.5M
Q1 24
$7.1M
Gross Margin
PSIX
PSIX
STOK
STOK
Q4 25
21.9%
Q3 25
23.9%
Q2 25
28.2%
Q1 25
29.7%
Q4 24
29.9%
Q3 24
28.9%
Q2 24
31.8%
Q1 24
27.0%
Operating Margin
PSIX
PSIX
STOK
STOK
Q4 25
12.7%
Q3 25
13.9%
Q2 25
16.9%
Q1 25
18.2%
70.2%
Q4 24
17.5%
-60.4%
Q3 24
16.3%
Q2 24
22.9%
Q1 24
11.2%
Net Margin
PSIX
PSIX
STOK
STOK
Q4 25
8.4%
Q3 25
13.5%
Q2 25
26.7%
Q1 25
14.1%
71.2%
Q4 24
16.1%
-46.4%
Q3 24
13.8%
Q2 24
19.5%
Q1 24
7.5%
EPS (diluted)
PSIX
PSIX
STOK
STOK
Q4 25
$0.69
Q3 25
$1.20
Q2 25
$2.22
Q1 25
$0.83
$1.90
Q4 24
$1.01
$-0.15
Q3 24
$0.75
Q2 24
$0.94
Q1 24
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PSIX
PSIX
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$41.3M
$274.8M
Total DebtLower is stronger
$96.6M
Stockholders' EquityBook value
$178.6M
$350.1M
Total Assets
$424.7M
$406.9M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PSIX
PSIX
STOK
STOK
Q4 25
$41.3M
Q3 25
$49.0M
Q2 25
$49.5M
Q1 25
$50.0M
$274.8M
Q4 24
$55.3M
$128.0M
Q3 24
$40.5M
Q2 24
$28.8M
Q1 24
$33.1M
Total Debt
PSIX
PSIX
STOK
STOK
Q4 25
$96.6M
Q3 25
$96.7M
Q2 25
$1.8M
Q1 25
$1.0M
Q4 24
$184.0K
Q3 24
$238.0K
Q2 24
$292.0K
Q1 24
$345.0K
Stockholders' Equity
PSIX
PSIX
STOK
STOK
Q4 25
$178.6M
Q3 25
$162.5M
Q2 25
$135.7M
Q1 25
$84.3M
$350.1M
Q4 24
$65.3M
$229.0M
Q3 24
$42.1M
Q2 24
$24.8M
Q1 24
$3.2M
Total Assets
PSIX
PSIX
STOK
STOK
Q4 25
$424.7M
Q3 25
$458.9M
Q2 25
$437.7M
Q1 25
$372.7M
$406.9M
Q4 24
$328.2M
$271.6M
Q3 24
$339.1M
Q2 24
$307.6M
Q1 24
$286.8M
Debt / Equity
PSIX
PSIX
STOK
STOK
Q4 25
0.54×
Q3 25
0.60×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.00×
Q3 24
0.01×
Q2 24
0.01×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PSIX
PSIX
STOK
STOK
Operating Cash FlowLast quarter
$-4.6M
$131.8M
Free Cash FlowOCF − Capex
$-7.6M
$131.7M
FCF MarginFCF / Revenue
-4.0%
83.0%
Capex IntensityCapex / Revenue
1.6%
0.1%
Cash ConversionOCF / Net Profit
-0.29×
1.17×
TTM Free Cash FlowTrailing 4 quarters
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PSIX
PSIX
STOK
STOK
Q4 25
$-4.6M
Q3 25
$3.3M
Q2 25
$16.7M
Q1 25
$8.8M
$131.8M
Q4 24
$32.7M
$-23.2M
Q3 24
$12.6M
Q2 24
$1.5M
Q1 24
$15.6M
Free Cash Flow
PSIX
PSIX
STOK
STOK
Q4 25
$-7.6M
Q3 25
$1.7M
Q2 25
$14.6M
Q1 25
$5.4M
$131.7M
Q4 24
$30.0M
$-23.2M
Q3 24
$12.1M
Q2 24
$822.0K
Q1 24
$14.8M
FCF Margin
PSIX
PSIX
STOK
STOK
Q4 25
-4.0%
Q3 25
0.8%
Q2 25
7.6%
Q1 25
4.0%
83.0%
Q4 24
20.8%
-102.7%
Q3 24
9.7%
Q2 24
0.7%
Q1 24
15.6%
Capex Intensity
PSIX
PSIX
STOK
STOK
Q4 25
1.6%
Q3 25
0.8%
Q2 25
1.1%
Q1 25
2.5%
0.1%
Q4 24
1.8%
0.2%
Q3 24
0.3%
Q2 24
0.6%
Q1 24
0.9%
Cash Conversion
PSIX
PSIX
STOK
STOK
Q4 25
-0.29×
Q3 25
0.12×
Q2 25
0.33×
Q1 25
0.46×
1.17×
Q4 24
1.40×
Q3 24
0.73×
Q2 24
0.07×
Q1 24
2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

STOK
STOK

Segment breakdown not available.

Related Comparisons